The FDA has signed off on a second COVID-19 booster for over 50’s.
The second booster shot of both the Pfizer-BioNTech and Moderna Covid-19 vaccines was authorized at the end of March without the opinion of an advisory committee of outside experts.
The FDA have said that they didn’t feel the need for outside opinion based on evidence from an Israeli study which showed that a fourth dose was safe among 600,000 people over the age of 60 who received the Pfizer vaccine. The agency lowered the recommended age to include many who are considered high risk in the 50 and up age group.
The study has also shown positive survival benefits and reduced hospitalisations. The FDA has decided not to wait for an Omicron-specific vaccine, as it’s not yet finished. They also haven’t ruled out the possibility of another shot being authorised later in the year.
COREX Logistics is a supply and logistics company with headquarters in Ireland, working with pharma and patients to facilitate improved healthcare worldwide.
Our expert international team works across an 80-country network, specialising in the EMEA region, providing the latest in clinical trial logistics technology and systems, cold-chain delivery, temperature-controlled transportation and storage services. From sourcing, procurement and customs clearance, to labelling, returns and destruction, we cover every link in the supply chain. We also run an established Named Patient Programme and provide Patient-Oriented services. With extensive knowledge and on-the-ground insight into our markets, we create innovative solutions with the ultimate goal of improving the lives of patients.
To learn more about our range of expert services, contact us today on email@example.com
If you found this article helpful, consider sharing it with others who might also benefit from it. Sharing knowledge is a wonderful thing to do and can be very helpful to others.
We’re here to help.
Email us at firstname.lastname@example.org or use our feedback form to send us your question.